The DEA's expedited rescheduling hearing runs June 29 to July 15. Who's testifying and what a Schedule III decision would change for operators.
Texas now counts THCA toward its THC limit, restricting THCA flower and concentrates. A look at the 2026 rule, the litigation, and the November federal cutover.
A regulatory guide to HHC vs THC: what HHC is, how it compares with delta-9 THC, and where its contested legal status stands in 2026.
The U.S. Embassy in Mexico warns World Cup travelers that importing marijuana, including medical cannabis, is illegal regardless of a U.S. state card.
A drug-testing trade group and a pharmaceutical company asked a federal appeals court to freeze marijuana rescheduling, reviving uncertainty over 280E relief and DEA registration.
THCA converts to delta-9 THC when heated. Here's how the law treats each and why the 2026 total-THC standard reshapes the THCA flower market.
How the law treats HHC vs THC, where they diverge, and what the 2026 federal changes mean for compliance.
Hemp companies have petitioned the Ninth and Fourth Circuits to overturn the DEA's Schedule I listing of HHC. Here's what HHC operators should do now.
State-by-state THCA status as of June 2026 with deep dives for Alabama, Georgia, North Carolina, South Carolina, and Texas — plus what changes when federal H.R. 5371 §781 takes effect November 12, 2026.
Texas hemp operators face TABC rule finalization, a March 31 smokable product ban, and HB 46 medical cannabis expansion reshaping the 2026 market.
Ontario's 2025 OCS THC potency testing pilot exposes label inflation in high-THC SKUs and reshapes supplier audits across the regulated adult-use catalog.
Oregon outdoor cannabis and hemp operators face 2025 wildfire smoke taint risks; practical guide to testing, labeling, and recall triage before packaging.
Greece's 2025 push to expand medical cannabis exports hinges on EU-GMP readiness across GACP cultivation, EudraLex Volume 4 manufacturing, and release.
Colombia's Decree 1138 of October 27, 2025 recognizes dried medical cannabis flower as a finished product, opening pharmacy dispensing and exports.
Health Canada removed the 60-day Notice of New Cannabis Product for dried and fresh cannabis in 2025, speeding flower launches without easing testing.
Colombia's 2025 VUCE foreign trade updates and Decree 1138 of 2025 reshape medical cannabis exports and authorize pharmacy flower under EU-GMP prescription.
Luxembourg ended prescription access to primarily THC-rich medical flower from January 1, 2025, favoring oils and standardized preparations for dosing.
Colombia's July 2025 draft decree and October 2025 Decree 1138 outline a prescription-only adult-use model dispensed through pharmacies under medical-gate.
Colombia's 2025 draft decree would authorize pharmacy sales of medical cannabis flower with new dispensing rules and marketing limits for licensed operators.
No — THCA is illegal outside Michigan's licensed cannabis system in 2026. CRA treats it as marijuana, not hemp. Retailer & consumer rules inside.
No — THCA smokables are a Class C felony in Alabama under HB 445 (July 2025). Edibles allowed under 10mg/serving, 40mg/package. ABC Board license required.
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
